[{"id":"15121b25-6844-4923-b564-1b27903b4d30","acronym":"","url":"https://clinicaltrials.gov/study/NCT05325801","created_at":"2022-04-13T11:55:04.792Z","updated_at":"2024-07-02T16:36:12.834Z","phase":"Phase 1","brief_title":"A Study of CAR-T Cells Targeting Both BCMA and GPRC5D in Treatment of Relapsed or Refractory Multiple Myeloma","source_id_and_acronym":"NCT05325801","lead_sponsor":"Zhejiang University","biomarkers":" GPRC5D","pipe":"","alterations":" ","tags":["GPRC5D"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BM-ca • OriC321"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 9","initiation":"Initiation: 04/01/2022","start_date":" 04/01/2022","primary_txt":" Primary completion: 03/01/2024","primary_completion_date":" 03/01/2024","study_txt":" Completion: 03/01/2025","study_completion_date":" 03/01/2025","last_update_posted":"2022-04-13"}]